ArticleJournal of medicinal chemistry2018

Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitor.

Yujun Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.